Gemma is Content Director at AIMed, with responsibility for engaging and growing the AIMed community and ownership for events from concept through to delivery. An experienced science graduate with a background in veterinary and nonprofit sectors, she also volunteers as a Wish Granter for Make a Wish UK.
Hamilton, what initially sparked your interest in smart health?
My interest in smart health was sparked by witnessing the immense potential of technology to revolutionize healthcare. Seeing how artificial intelligence, data analytics, and advanced technologies can enhance patient care and improve outcomes fascinates me. I was drawn to the idea of leveraging these tools to solve complex healthcare challenges and make a positive impact on people’s lives.
What are the primary obstacles you encounter in your clinical practice, and to what degree do you believe artificial intelligence can assist in addressing them?
One of the primary obstacles in clinical practice is the overwhelming amount of data that healthcare professionals need to analyze and interpret. Time constraints and the complexity of medical information can make it challenging to derive meaningful insights. Artificial intelligence can play a crucial role in addressing these obstacles by efficiently processing and analyzing vast amounts of data, identifying patterns and trends, and providing decision support to healthcare providers. AI has the potential to enhance accuracy, speed, and efficiency in diagnosis, treatment planning, and patient monitoring.
In the field of cardiology, where do you foresee artificial intelligence making the most significant impact?
Artificial intelligence holds immense promise in the field of cardiology. One area where it can make a significant impact is in the early detection and diagnosis by detecting subtle patterns and indicators humans may overlook. Additionally, AI can aid in risk stratification, treatment planning, predicting patient outcomes, personalized treatment approaches, optimize cardiac interventions, and improve overall cardiovascular care.
As the Director of the Clemson University – MUSC Artificial Intelligence Hub, how can initiatives like this contribute to translating AI research into clinical practice?
Initiatives like the Clemson University – MUSC Artificial Intelligence Hub play a vital role in bridging the gap between AI research and clinical practice. These initiatives facilitate collaboration between researchers, clinicians, and industry partners, fostering a multidisciplinary approach to solving healthcare challenges. The Hub provides a platform for knowledge exchange, supporting the development and validation of AI algorithms and tools specific to clinical needs. It also facilitates training programs, workshops, and symposiums to educate healthcare professionals about AI applications. By fostering these collaborations and knowledge-sharing initiatives, we can accelerate the translation of AI research into clinical practice, ultimately benefiting patients and healthcare providers.
Ai-Med’s mission is to “change healthcare, one connection at a time.” What kind of impact has the Global Summit had on the AI healthcare community?
The AIMed Global Summit has had a profound impact on the AI healthcare community. The summit provides a platform for experts, innovators, and thought leaders to come together, exchange ideas, and share their experiences in harnessing AI for healthcare. It promotes networking, collaboration, and the formation of strategic partnerships. In many ways, Ai-Med and especially the Global Summit were my inspiration for creating the CU-MUSC AI Hub.
You have already achieved a great deal in your career. To what do you attribute your success?
Any accomplishments I have I owe to teamwork. Collaborating with talented colleagues and fostering strong partnerships has been instrumental in achieving successful outcomes. Additional important components are maintaining a focus on innovation, perseverance in the face of challenges, and a daily recommitment to excellence.
We believe in changing healthcare one connection at a time. If you are interested in the opinions in this piece, in connecting with the author, or the opportunity to submit an article, let us know. We love to help bring people together! [email protected]
Dr. Baker is a pediatric cardiologist who is dual board certified in pediatric and adult congenital heart disease. He received his B.S. in biology from the University of Michigan, his M.D. from Albany Medical College and all his postgraduate medical training at the Medical University of South Carolina where he is an associate professor of pediatrics and public health. He also completed a master’s program in Biomedical Data Science and Informatics at Clemson University. He has authored over 60 peer-reviewed journal publications, and holds a U.S. patent in interventional image guidance. His research focus is on applied artificial intelligence in medicine including the application of machine learning, deep learning, computer vision in congenital heart disease. He is also the Director of the Clemson University – MUSC Artificial Intelligence Hub.